Who has invested in Moximed?

Elevage Medical Technologies, Advent Life Sciences, SR ONE are named among the investors backing Moximed.

Moximed Funding: $184M Raised, Series D (2024)

Moximed funding overview

Moximed is a Biotech company based in California. Moximed has raised $184M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in August 2024. The round record for Moximed runs through 2024; nothing later has been disclosed. Investors on record include Elevage Medical Technologies, Advent Life Sciences, SR ONE. 3 distinct backers are named across the disclosed rounds.

Moximed at a glance

Total raised: $184M
Latest round: Series D
Latest round date: August 2024
Industry: Biotech
Headquarters: California
Notable investors: Elevage Medical Technologies, Advent Life Sciences, SR ONE

Frequently asked about Moximed funding

How much has Moximed raised?: Moximed has raised $184M in total disclosed funding across the rounds on record.
Who has invested in Moximed?: Elevage Medical Technologies, Advent Life Sciences, SR ONE are named among the investors backing Moximed.
What was the latest Moximed funding round?: The most recent disclosed round is a Series D, announced in August 2024.
Where is Moximed based?: Moximed is based in California.
What sector does Moximed operate in?: Moximed is tracked under Biotech from California, with $184M in disclosed funding.
When did Moximed last raise?: The last disclosed Moximed round closed in August 2024 at Series D.

We update the Moximed record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in California and their backers are listed below.

Moximed Funding: $184M Raised, Series D (2024)

Moximed funding overview

Moximed at a glance

Frequently asked about Moximed funding

Moximed founders (1)

Companies related to Moximed (40)

Browse related funding lists (5)